Most of these pathogenic variants affect the bone morphogenetic protein receptor type II (BMPR2) gene and are identified in 50–80% of HPAH patients and in about 15–20% of idiopathic PAH (IPAH) patients [3,4]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.